Position in INVA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,449,047
+$1,270,531 QoQ
Shares Held
195,907
+43.6% QoQ
Ownership
0.271%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#54
of 307 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $556,047,667 across 189 Biotechnology names. INVA ranks #33 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,659 | $81,471,112 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,294 | $66,211,127 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
392,811 | $22,476,644 | |
| 4 | INCY |
Incyte Corp
|
191,312 | $21,687,128 | |
| 5 | CYTK |
Cytokinetics Inc
|
214,535 | $18,276,236 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
54,623 | $17,265,784 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
185,820 | $15,157,337 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,152,154 | $13,429,440 |
All Filings in INVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,449,047 | 195,907 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,178,516 | 136,417 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,712,483 | 135,692 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,663,277 | 145,933 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,932,798 | 145,983 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,235,334 | 178,452 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,125,116 | 180,122 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,349,304 | 69,876 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $995,200 | 60,683 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $992,550 | 65,128 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,154,077 | 71,950 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $885,800 | 68,191 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $936,188 | 73,542 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $687,971 | 61,153 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $931,541 | 70,305 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $736,596 | 63,445 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $942,942 | 63,885 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,238,303 | 63,995 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,950,888 | 113,095 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,273,078 | 136,031 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,617,246 | 120,600 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $880,428 | 73,676 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,294,753 | 104,500 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $2,347,853 | 224,675 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,704,650 | 121,935 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,642,342 | 139,655 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||